Sinovac Receives Clinical Trial Approval for Sabin-IPV Candidate
December 10, 2015 at 05:48 AM EST
Sinovac Biotech Ltd. (NASDAQ: SVA) today announced that the Company has obtained approval to begin human clinical trials on its Sabin ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.